HomeIDXG • OTCMKTS
add
Interpace Biosciences Inc
Previous close
$1.89
Day range
$1.85 - $1.90
Year range
$1.85 - $1.90
Market cap
51.25M USD
Avg Volume
4.66K
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 9.22M | -25.11% |
Operating expense | 4.47M | -23.58% |
Net income | 22.66M | 683.44% |
Net profit margin | 245.63 | 946.12% |
Earnings per share | — | — |
EBITDA | 1.70M | -46.48% |
Effective tax rate | -1,382.21% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.50M | 71.46% |
Total assets | 33.84M | 128.76% |
Total liabilities | 11.48M | -32.54% |
Total equity | 22.36M | — |
Shares outstanding | 27.70M | — |
Price to book | 0.37 | — |
Return on assets | 17.19% | — |
Return on capital | 31.44% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | 22.66M | 683.44% |
Cash from operations | 2.14M | 80.57% |
Cash from investing | -38.00K | 70.54% |
Cash from financing | -1.02M | 40.36% |
Net change in cash | 1.08M | 265.95% |
Free cash flow | 2.01M | 132.75% |
About
Founded
1986
Headquarters
Website
Employees
111
